What is Market Cap of Franklin Strategic Series - Franklin Strategic Biotechnology Discovery Fund Class A?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Franklin Strategic Series - Franklin Strategic Biotechnology Discovery Fund Class A market cap is N/A.
What is the 52-week high for Franklin Strategic Series - Franklin Strategic Biotechnology Discovery Fund Class A?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Franklin Strategic Series - Franklin Strategic Biotechnology Discovery Fund Class A 52 week high is N/A as of October 10, 2025.
What is the 52-week low for Franklin Strategic Series - Franklin Strategic Biotechnology Discovery Fund Class A?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Franklin Strategic Series - Franklin Strategic Biotechnology Discovery Fund Class A 52 week low is N/A as of October 10, 2025.
What is the PE ratio of Franklin Strategic Series - Franklin Strategic Biotechnology Discovery Fund Class A?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Franklin Strategic Series - Franklin Strategic Biotechnology Discovery Fund Class A’s P/E ratio is None.
What is the Price-to-Book ratio of Franklin Strategic Series - Franklin Strategic Biotechnology Discovery Fund Class A?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Franklin Strategic Series - Franklin Strategic Biotechnology Discovery Fund Class A P/B ratio is None.
What is Franklin Strategic Series - Franklin Strategic Biotechnology Discovery Fund Class A's EBITDA?
EBITDA is a widely used measure of corporate profitability. It stands for Earnings before Interest, Taxes, Depreciation, and Amortization. It attempts to reflect the cash profit generated by a company’s operations. Franklin Strategic Series - Franklin Strategic Biotechnology Discovery Fund Class A's EBITDA is N/A.
What is the 50-day moving average of Franklin Strategic Series - Franklin Strategic Biotechnology Discovery Fund Class A?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Franklin Strategic Series - Franklin Strategic Biotechnology Discovery Fund Class A 50-day moving average is N/A.
How many employess does Franklin Strategic Series - Franklin Strategic Biotechnology Discovery Fund Class A has?
Franklin Strategic Series - Franklin Strategic Biotechnology Discovery Fund Class A has N/A employees.
